Shots: The approval is based on the study assessing Egaten (triclabendazole) in patients with fascioliasis aged ≥ 6yrs. Novartis’ Egaten is in use since 2005 by WH, serving 2M fascioliasis […]readmore
Tags : liver fluke infestation
Latest Posts
Categories
Related Topics
AbbVie
Acceptance
Acquire
Agreement
Amgen
approval
AstraZeneca
Bayer
Biosimilar
BMS
Boehringer Ingelheim
Collaborates
Collaboration
Commercialize
COVID-19
Develop
Development
Eli Lilly
Exclusive
FDA
Gilead
GSK
Janssen
Launches
License
License Agreement
Lilly
Merck
Novartis
P-III
patients
Pfizer
receives
Regeneron
Report
reports
results
Roche
Sanofi
Signs
study
Takeda
Treat
Treatment
US